TherapeuticsMD (TXMD)
(Delayed Data from NSDQ)
$1.79 USD
-0.01 (-0.56%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $1.74 -0.05 (-2.79%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.79 USD
-0.01 (-0.56%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $1.74 -0.05 (-2.79%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Is the Options Market Predicting a Spike in TherapeuticsMD (TXMD) Stock?
by Zacks Equity Research
Investors need to pay close attention to TherapeuticsMD (TXMD) stock based on the movements in the options market lately.
Options Traders Expect Huge Moves in TherapeuticsMD (TXMD) Stock
by Zacks Equity Research
Investors in TherapeuticsMD (TXMD) need to pay close attention to the stock based on moves in the options market lately.
Implied Volatility Surging for TherapeuticsMD, Inc. (TXMD) Stock Options
by Zacks Equity Research
Investors in TherapeuticsMD, Inc. (TXMD) need to pay close attention to the stock based on moves in the options market lately.
TherapeuticsMD (TXMD) Catches Eye: Stock Moves 5.9% Higher
by Zacks Equity Research
TherapeuticsMD, Inc. (TXMD) moved big last session, as its shares jumped almost 6% on the day.
Are Options Traders Betting on a Big Move in TherapeuticsMD (TXMD) Stock?
by Zacks Equity Research
Investors in TherapeuticsMD (TXMD) need to pay close attention to the stock based on moves in the options market lately.
Are Options Traders Betting on a Big Move in TherapeuticsMD (TXMD) Stock?
by Zacks Equity Research
TherapeuticsMD (TXMD) warrants investors' attention based on moves in the options market lately.
Are Options Traders Betting on a Big Move in TherapeuticsMD (TXMD) Stock?
by Zacks Equity Research
Options traders are pricing in a big move for TherapeuticsMD (TXMD) shares as it has huge implied volatility.
TherapeuticsMD Falls on Likely Delay in TX-004HR Approval
by Zacks Equity Research
Shares of TherapeuticsMD, Inc. (TXMD) have declined almost 25% since Monday when it received a letter from the FDA identifying deficiencies in the new drug application (NDA) for its dyspareunia drug, TX-400HR filed last July
TherapeuticsMD's Rejoice Study Data Published in Journal
by Zacks Equity Research
TherapeuticsMD, Inc. (TXMD) announced the publication of two manuscripts detailing with the results of the company's pivotal phase III study (Rejoice) in Menopause: The Journal of The North American Menopause Society.